mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2251-2255

  Tait Kamradt, Amelia ^a   Clancy, Joanna ^a   Cronan, Melissa ^a   Dib Hajj, Fadia ^a   Wondrack, Lillian ^a   Yuan, Wei ^a   Sutcliffe, Joyce ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; MIKAMYCIN B;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; ENZYME SPECIFICITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0030874070     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2251     Document Type: Article

References (40)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Arthur, M., A. Andremont, and P. Courvalin. 1987. Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob. Agents Chemother. 31:404-409.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current protocols in molecular biology, vol. 1, p. 2.4.1-2.4.4. John Wiley & Sons, New York, N.Y.
4. Avery, O. T., C. M. MacLeod, and M. McCarty. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. J. Exp. Med. 79:137-158.
5. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
6. Bright, G. M., A. A. Nagel, J. Bordner, K. A. Desai, J. N. Dibrino, J. Nowakowska, L. Vincent, R. M. Watrous, F. C. Sciavolino, A. R. English, J. A. Retsema, M. R. Anderson, L. A. Brennan, R. J. Borovoy, C. R. Cimochowski, J. A. Faiella, A. E. Girard, D. Girard, C. Herbert, M. Manousos, and R. Mason. 1988. Synthesis and in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives: a new class of macrolide antibiotics, the azalides. J. Antibiot. 41:1028-1047.
7. Chang, A. C. Y., and S. N. Cohen. 1978. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 134:1141-1156.
8. Clancy, J., J. Petitpas, F. Dib-Hajj, W. Yuan, M. Cronan, A. V. Kamath, J. Bergeron, and J. A. Retsema. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867-879.
9. Claverys, J.-P., A. Dintilhac, E. V. Pestova, B. Martin, and D. A. Morrison. 1995. Construction and evaluation of new drug-resistance cassettes for gene disruption mutagenesis in Streptococcus pneumoniae, using an ami test platform. Gene 164:123-128.
10. Cornaglia, G., M. Ligozzi, A. Mazzariol, M. Valentini, G. Orefici, the Italian Surveillance Group for Antimicrobial Resistance, and R. Fontana. 1996. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg. Infect. Dis. 2:339-342.
11. Devine, S. E., and J. D. Boeke. 1994. Efficient integration of artificial transposons into plasmid targets in vitro: a useful tool for DNA mapping, sequencing and genetic analysis. Nucleic Acids Res. 22:3765-3772.
12. Fasola, E. L., S. Bajaksouzian, P. C. Appelbaum, and M. R. Jacobs. 1997. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob. Agents Chemother. 41:129-134.
13. Fraimow, H., and C. Knob. 1997. Amplification of macrolide efflux pumps msr and mef from Enterococcus faecium by polymerase chain reaction, abstr. A-125, p. 22. In Program and abstracts of the 97th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
14. Gómez, J., J. Ruiz-Gómez, J. L. Hernández-Cardona, M. L. Núñez, M. Canteras, and M. Valdés. 1994. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a prospective study in Murcia, Spain, 1983-1992. Chemotherapy (Basel) 40:299-303.
15. Gossele, F., P. Blain, T. Marneffe, and A. Biot. 1991. High-performance liquid chromatographic determination of virginiamycin in Stafac, premixes and animal feeds. Analyst 116:1373-1380.
16. Haverstein, L. S., G. Coomaraswamy, and D. A. Morrison. 1995. An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc. Natl. Acad. Sci. USA 92:11140-11144.
17. Jaeger, W. 1995. GenBank accession no. U43535.
18. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
19. Lewis, K. 1994. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biol. Sci. 19:119-123.
20. McCracken, G. H., Jr. 1995. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr. Infect. Dis. J. 14:424-428.
21. Milton, E. D., C. L. Hewitt, and C. R. Harwood. 1992. Cloning and sequencing of a plasmid-mediated erythromycin resistance determinant from Staphylococcus xylosus. FEMS Microbiol. Lett. 97:141-147.
22. National Committee for Clinical Laboratory Standards. 1995. Suggested groupings of U.S. FDA-approved antimicrobial agents that should be considered for routine testing and reporting on fastidious organisms by clinical microbiology laboratories, Table 1A. In J. H. Jorgensen, W. A. Craig, G. V. Doern, M. J. Ferraro, S. M. Finegold, J. Fung-Tomc, S. L. Hansen, J. Hindler, D. A. Preston, L. B. Reller, J. M. Swenson, F. C. Tenover, M. A. Wikler, and W. R. Wilson (ed.), Performance standards for antimicrobial susceptibility testing, vol. 15, number 14. National Committee for Clinical Laboratory Standards, Wayne, Pa.
23. Nelson, C. T., E. O. Mason, Jr., and S. L. Kaplan. 1994. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13:585-589.
24. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
25. Phillips, G., D. Parratt, G. V. Orange, I. Harper, H. McEwan, and N. Young. 1990. Erythromycin-resistant Streptococcus pyogenes. J. Antimicrob. Chemother. 25:723-724.
26. Ross, J. I., E. A. Eady, J. H. Cove, and S. Baumberg. 1995. Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene 153:93-98.
27. Ross, J. I., E. A. Eady, J. H. Cove, W. J. Cunliffe, S. Baumberg, and J. C. Wootton. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Molec. Microbiol. 4:1207-1214.
28. Ross, J. I., A. M. Farrell, E. A. Eady, J. H. Cove, and W. J. Cunliffe. 1989. Characterization and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J. Antimicrob. Chemother. 24:851-862.
29. Scott, R. J. D., J. Naidoo, N. F. Lightfoot, and R. C. George. 1989. A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin. Epidemiol. Infect. 102:95-91.
30. Seppälä, H., A. Nissinen, H. Järvinen, S. Huovinen, T. Henriksson, E. Herva, S. E. Holm, M. Jahkola, M.-L. Katila, T. Klaukka, S. Kontiainen, O. Liimatainen, S. Oinonen, L. Passi-Metsomaa, and P. Huovinen. 1992. Resistance to erythromycin in Group A streptococci. N. Engl. J. Med. 326:292-297.
31. Seppälä, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
32. Shortridge, V. D., R. K. Flamm, N. Ramer, J. Beyer, and S. K. Tanaka. 1996. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 26:73-78.
33. Stingemore, N., G. R. J. Francis, M. Toohey, and D. B. McGechie. 1989. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med. J. Aust. 150:626-631.
34. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
35. Sutcliffe, J., and M. Jacobs. Unpublished data.
36. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
37. Telenti, A., C. Bernasconi, and W. R. Jacobs, Jr. 1996. GenBank accession no. U46844.
38. Thornsberry, C., S. D. Brown, Y. C. Yee, S. K. Bouchillon, J. K. Marler, and T. Rich. 1993. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S. Effect on susceptibility to oral cephalosporins. Infections in Medicine 10:15-24.
39. Trieu-Cuot, P., C. Poyart-Salmeron, C. Carlier, and P. Courvalin. 1990. Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn/545. Nucleic Acids Res. 18:3660.
40. Welby, P. E., D. S. Keller, J. L. Cromien, P. Tebas, and G. A. Storch. 1994. Resistance to penicillin and non-β-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr. Infect. Dis. J. 13:281-287.